P01.038 Drug resistance and recurrence in glioblastoma: molecular cytogenetic analysis in paired primary and recurrent form

por Šporiková, Z, Megová Houdová, M, Trojanec, R, Kalita, O, Vrbková, J, Drábek, J, Koudeláková, V, Hajdúch, M
Publicado en Neuro Oncol (2018)

P06.09 Genetic alterations in patients with resection of primary glioblastoma multiforme gr.IV

por Trojanec, R., Kalita, O., Megova, M., Sporikova, Z., Vrbkova, J., Vaverka, M., Hrabalek, L., Tuckova, L., Hajduch, M.
Publicado en Neuro Oncol (2016)

P06.10 A retrospective single-center study of IDH mutations in gliomas

por Megova, M., Drabek, J., Trojanec, R., Koudelakova, V., Vrbkova, J., Kalita, O., Mlcochova, S., Rabcanova, M., Tuckova, L., Hajduch, M.
Publicado en Neuro Oncol (2016)

P08.70 Prognostic and predictive factors in primary Glioblastoma Multiforme WHO grade IV patients with resection: A single-institution study

por Kalita, O., Hajduch, M., Trojanec, R., Megova, M., Vaverka, M., Hrabalek, L., Zlevorova, M., Drabek, J., Tuckova, L., Vrbková, J.
Publicado en Neuro Oncol (2016)

P14.68 Life expectancy in biopsied GBM patients: a single-centre experience

por Kalita, O, Sporikova, Z, Halaj, M, Cwiertka, K, Vaverka, M, Hrabalek, L, Trojanec, R, Hajduch, M, Drabek, J, Vrbkova, J
Publicado en Neuro Oncol (2019)

P01.098 Have we been still defeated with treatment of GBM IDH wild-type recurrency

por Kalita, O, Vaverka, M, Hrabalek, L, Vrana, D, Trojanec, R, Sporikova, Z, Hajduch, M, Drabek, J, Hok, P, Hlustik, P, Tuckova, L, Vrbkova, J
Publicado en Neuro Oncol (2018)